Neurocrine Bio. (NBIX) PT Raised to $155 at Truist Securities
Tweet Send to a Friend
Truist Securities analyst Danielle Brill raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $155.00 (from $140.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
